Literature DB >> 1139138

Injury of the facial nerve during surgery of the parotid gland.

C M Ward.   

Abstract

The notes of 158 patients who had undergone surgery of the parotid gland for benign and malignant disease were studied to discover the circumstances in which the facial nerve might be injured. Limited surgery carried as great a risk of injury to the facial nerve as during extended surgery. Extended surgery provided greater risk of injury to the facial nerve on secondary exploration (71 per cent) than on primary exploration (6-5 per cent). It is concluded that every primary exploratory procedure of the parotid gland should be a formal conservative parotidectomy unless the tumour is obviously malignant.

Entities:  

Mesh:

Year:  1975        PMID: 1139138     DOI: 10.1002/bjs.1800620518

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  [Is dissection of the facial nerve avoidable during surgery for benign parotid tumors? : Parotid surgery without facial nerve dissection].

Authors:  K Mantsopoulos; B Bär; H Iro
Journal:  HNO       Date:  2020-03       Impact factor: 1.284

2.  Microsurgical dissection of facial nerve in parotidectomy: a discussion of techniques and long-term results.

Authors:  Fabio Nicoli; Christopher D'Ambrosia; Davide Lazzeri; Georgios Orfaniotis; Pedro Ciudad; Michele Maruccia; Li Tzong Shiun; Bulent Sacak; Shih-Heng Chen; Hung-Chi Chen
Journal:  Gland Surg       Date:  2017-08

3.  A Transoral Excision of a Deep Parotid Lobe Lesion Using Ultrasound-Guided Wire Localization: A Multi-disciplinary Team Approach.

Authors:  A Tahim; H Aludden; S Jawad; Z Sadiq
Journal:  J Maxillofac Oral Surg       Date:  2018-07-26

4.  Incidence of postoperative facial weakness in parotid tumor surgery: a tumor subsite analysis of 794 parotidectomies.

Authors:  Hokyung Jin; Bo Young Kim; Heejung Kim; Eunkyu Lee; Woori Park; Sungyong Choi; Man Ki Chung; Young-Ik Son; Chung-Hwan Baek; Han-Sin Jeong
Journal:  BMC Surg       Date:  2019-12-26       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.